Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

On the diagnosis and treatment of hyperprolactinemia syndrome

DOI: https://doi.org/10.29296/25879979-2021-03-06
Download full text PDF
Issue: 
3
Year: 
2021

1. Vsevolod V. Skvortsov, Dr. of Sciences (Medical), Associate Professor, Internal Medicine Department, Volgograd state medical university, Russian Health Ministry, [email protected] 2. Aleksandr V. Tumarenko, PhD in Medical Sciences, Assistant of the Department of Internal Medicine, Volgograd state medical university, Russian Health Ministry, [email protected] 3. Nikita D. Matveev, student, Volgograd state medical university, Russian Health Ministry, [email protected]

Hyperprolactinemia – a condition characterized by high levels of prolactin (pituitary hormone) in the blood. Most often hyperprolactinemia occurs in young women aged 25-40 years, much less-in men of the same age. Hyperprolactinemia is the pathogenetic basis of a number of endocrine disorders, neuroendocrine syndromes and infertility in almost 35-40% of women. This article is devoted to the etiology, pathogenesis, clinic, diagnosis and treatment of hyperprolactinemia syndrome.
Keywords: 
hyperprolactinemia
diagnosis
treatment

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Balan V.E. Vozmozhnosti primenenija rastitel'nyh preparatov pri razlichnyh sostojanijah, obuslovlennyh giperprolaktinemiej. Effektivnaja farmakoterapija v akusherstve i ginekologii. 2007. № 3, c. 28-33.
  2. Dedov I.I., Mel'nichenko G.A., Romantsova T.I. Sindrom giperprolaktinemii. M., 2004. 304 s. 
  3. Vishnevskij A.S., Safronnikova N.R., Mel'nikova N.Ju., Grigor'eva T.A. Novye podhody k sindromu giperprolaktinemii. Zhurnal akusherstva i zhenskih boleznej. – 2000. - Vyp. 1, T. XLIX. - S. 39-41.
  4. Ovsjannikova T.V. Giperprolaktinemija // Meditsina dlja vseh. 1997, № 1 (2), s.19-21.
  5. Ovsjannikova T.V. Endokrinnoe besplodie u zhenschin pri giperprolaktinemii. Sonsilium-medicum (ginekologija). 2004, t. 6, №6. 2004.
  6. Smetnik V.P. Giperprolaktinemija i narushenija funktsii reproduktivnoj sistemy // Akusherstvo i ginekologija. 1990, № 4, s. 75-79.
  7. Smetnik V.P., Butareva L.B. Opyt primenenija fitopreparata «Tsiklodinon» (agnukaston) u patsientok s nedostatochnost'ju funktsii zheltogo tela i giperprolaktinemiej. Problemy reproduktsii, 2005, № 5, s. 1-4.
  8. Kilicdaga E.B. Tsiklodinon (agnukaston) i bromokriptin dlja lechenija giperprolaktinemii i mastalgii //International Journal of Gynecology and Obstetrics. 2004, № 85, s. 292-293.
  9. Turmuhambetova B.T., Kozlova L.K., Dzhulamanova A.B., Nikonova E.N. Osobennosti reproduktivnoj funktsii zhenschin s revmatoidnym artritom. Vrach, 2020; 5 (31): 18-22 https://doi.org/10.29296/25877305-2020-05-04
  10. Bulgakova S.V., Treneva E.V., Zaharova N.O., Nikolaeva A.V. Vlijanie starenija nadpochechnikov na rabotu razlichnyh organov i sistem. Vrach, 2020; (6): 34-39 https://doi.org/10.29296/25877305-2020-06-06
  11. Smirnova O., Tsukanov V., Sinjakov A., Moskalenko O., Elmanova N., Ovcharenko E., Titova N. Pokazateli perekisnogo okislenija lipidov i antioksidantnoj zaschity pri hronicheskom atroficheskom gastrite, assotsiirovannom s Helicobacter pylori . Vrach, 2019; (11): 41-45 https://doi.org/10.29296/25877305-2019-11-08
  12. Amlaev K.R. Diabet kak problema meditsinskoj profilaktiki. Vrach, 2021; (3): 9-14 https://doi.org/10.29296/25877305-2021-03-02